Pathological Aging of the Brain: An Overview

The number of elderly people is increasing rapidly and, therefore, an increase in neurodegenerative and cerebrovascular disorders causing dementia is expected. Alzheimer disease (AD) is the most common cause of dementia. Vascular dementia, dementia with Lewy bodies, and frontotemporal dementia are the most frequent causes after AD, but a large proportion of patients have a combination of degenerative and vascular brain pathology. Characteristic magnetic resonance (MR) imaging findings can contribute to the identification of different diseases causing dementia. The MR imaging protocol should include axial T2-weighted images (T2-WI), axial fluid-attenuated inversion recovery (FLAIR) or proton density-weighted images, and axial gradient-echo T2*-weighted images, for the detection of cerebrovascular pathology. Structural neuroimaging in dementia is focused on detection of brain atrophy, especially in the medial temporal lobe, for which coronal high resolution T1-weighted images perpendicular to the long axis of the temporal lobe are extremely important. Single photon emission computed tomography and positron emission tomography may have added value in the diagnosis of dementia and may become more important in the future, due to the development of radioligands for in vivo detection of AD pathology. New functional MR techniques and serial volumetric imaging studies to identify subtle brain abnormalities may also provide surrogate markers for pathologic processes that occur in diseases causing dementia and, in conjunction with clinical evaluation, may enable a more rigorous and early diagnosis, approaching the accuracy of neuropathology.

[1]  M. Oda,et al.  Progressive supranuclear palsy: MRI and pathological findings , 1996, Neuroradiology.

[2]  B. Drayer,et al.  Imaging of the Aging Brain , 2005 .

[3]  G. Frisoni,et al.  Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  P. Scheltens,et al.  Impact of Age-Related Cerebral White Matter Changes on the Transition to Disability – The LADIS Study: Rationale, Design and Methodology , 2004, Neuroepidemiology.

[5]  Nick C Fox,et al.  Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  S. Gauthier,et al.  Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors , 2004, Journal of the Neurological Sciences.

[7]  F Barkhof,et al.  Enlarged Virchow-Robin spaces: do they matter? , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  Alan A. Wilson,et al.  In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[9]  Karen J. Ferguson,et al.  Enlarged perivascular spaces are associated with cognitive function in healthy elderly men , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  E G Tangalos,et al.  1H MR spectroscopy in common dementias , 2004, Neurology.

[11]  Nick C. Fox,et al.  Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease , 2004, NeuroImage.

[12]  Agneta Nordberg,et al.  PET imaging of amyloid in Alzheimer's disease , 2004, The Lancet Neurology.

[13]  M. F. Falangola,et al.  Visualization of β‐amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents , 2004, Magnetic resonance in medicine.

[14]  M. Citron,et al.  Strategies for disease modification in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[15]  Huali Wang,et al.  Prolongation of T2 relaxation times of hippocampus and amygdala in Alzheimer's disease , 2004, Neuroscience Letters.

[16]  Matthias J. Müller,et al.  Ultrastructural Hippocampal and White Matter Alterations in Mild Cognitive Impairment: A Diffusion Tensor Imaging Study , 2004, Dementia and Geriatric Cognitive Disorders.

[17]  A. Haley,et al.  Shortening of hippocampal spin-spin relaxation time in probable Alzheimer's disease: a 1H magnetic resonance spectroscopy study , 2004, Neuroscience Letters.

[18]  M. O’Sullivan,et al.  Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia , 2004, Neurology.

[19]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[20]  C. Jack,et al.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.

[21]  H S Markus,et al.  Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  P. Scheltens,et al.  Thalamic Lesions in Vascular Dementia: Low Sensitivity of Fluid-Attenuated Inversion Recovery (FLAIR) Imaging , 2004, Stroke.

[23]  G K Wenning,et al.  Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  P. Scheltens,et al.  Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability , 1995, Journal of Neurology.

[25]  P. Jolles,et al.  An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains , 2004, Experimental Brain Research.

[26]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[27]  P. Doraiswamy,et al.  In vivo amyloid imaging in Alzheimer’s disease , 2004, Neuroradiology.

[28]  I G McKeith,et al.  Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease , 2003, Neurology.

[29]  Sung-Cheng Huang,et al.  2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[30]  F Barkhof,et al.  Identifying confounds to increase specificity during a “no task condition” Evidence for hippocampal connectivity using fMRI , 2003, NeuroImage.

[31]  Nick C Fox,et al.  Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC , 2003, Journal of neurology, neurosurgery, and psychiatry.

[32]  J. Barrio,et al.  Molecular-Imaging Probe 2-(1-{6-[(2-Fluoroethyl)(Methyl) Amino]-2-Naphthyl}Ethylidene) Malononitrile Labels Prion Plaques In Vitro , 2003, The Journal of Neuroscience.

[33]  Atsuo Tanaka,et al.  High b value diffusion-weighted imaging is more sensitive to white matter degeneration in Alzheimer's disease , 2003, NeuroImage.

[34]  Frederik Barkhof,et al.  Operational Definitions for the NINDS-AIREN Criteria for Vascular Dementia: An Interobserver Study , 2003, Stroke.

[35]  Maria Assunta Rocca,et al.  Evidence of subtle gray-matter pathologic changes in healthy elderly individuals with nonspecific white-matter hyperintensities. , 2003, Archives of neurology.

[36]  Thomas Wisniewski,et al.  Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging , 2003, Magnetic resonance in medicine.

[37]  Eric E. Smith,et al.  Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.

[38]  F Barkhof,et al.  Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD , 2003, Neurology.

[39]  W. M. van der Flier,et al.  Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease , 2003, Neurology.

[40]  Clifford R Jack,et al.  Neuroimaging in Alzheimer disease: an evidence-based review. , 2003, Neuroimaging clinics of North America.

[41]  G. Román,et al.  Vascular Dementia: Distinguishing Characteristics, Treatment, and Prevention , 2003, Journal of the American Geriatrics Society.

[42]  J. Baron,et al.  Mild cognitive impairment , 2003, Neurology.

[43]  M. Emre Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.

[44]  Emma J. Burton,et al.  A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry , 2003, NeuroImage.

[45]  R. Coleman,et al.  Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. , 2003, Radiology.

[46]  Jean-Claude Baron,et al.  Early diagnosis of alzheimer’s disease: contribution of structural neuroimaging , 2003, NeuroImage.

[47]  Nick C Fox,et al.  Computer-assisted imaging to assess brain structure in healthy and diseased brains , 2003, The Lancet Neurology.

[48]  K. Jellinger,et al.  The pathology of ischemic-vascular dementia An update , 2002, Journal of the Neurological Sciences.

[49]  Thomas Wisniewski,et al.  Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging , 2002, Neurobiology of Disease.

[50]  M. Kameyama,et al.  White Matter Lesions and Dementia MRI‐Pathological Correlation , 2002, Annals of the New York Academy of Sciences.

[51]  E. Tangalos,et al.  Comparative Diagnostic Utility of Different MR Modalities in Mild Cognitive Impairment and Alzheimer’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.

[52]  H. Chui,et al.  Subcortical ischaemic vascular dementia , 2002, The Lancet Neurology.

[53]  Kevin M Bradley,et al.  Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. , 2002, Brain : a journal of neurology.

[54]  W. M. van der Flier,et al.  Cognitive decline in AD and mild cognitive impairment is associated with global brain damage , 2002, Neurology.

[55]  et al.,et al.  Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.

[56]  S. Blackband,et al.  MR microscopy and high resolution small animal MRI: applications in neuroscience research , 2002, Progress in Neurobiology.

[57]  J. O'Brien,et al.  A Comprehensive Review of Proton Magnetic Resonance Spectroscopy Studies in Dementia and Parkinson’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.

[58]  N. Schuff,et al.  Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus , 2002, Neurology.

[59]  A. Vighetto,et al.  Thalamic venous infarction as a cause of subacute dementia. , 2002, Neurology.

[60]  Frederik Barkhof,et al.  Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion , 2002, The Lancet Neurology.

[61]  Ocular apraxia in recessive ataxia. , 2002, Archives of neurology.

[62]  Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease. , 2002, Archives of neurology.

[63]  P. Scheltens,et al.  Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.

[64]  N. Schuff,et al.  Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD , 2002, Neurology.

[65]  Masatoshi Itoh,et al.  Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease. , 2002, The American journal of psychiatry.

[66]  D. Prayer,et al.  Sequential MRI in a case of Creutzfeldt-Jakob disease , 2002, Neuroradiology.

[67]  Hirofumi Sakurai,et al.  Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease , 2002, Neuroscience Letters.

[68]  PhD Jaap Valk MD,et al.  Magnetic Resonance in Dementia , 2002, Springer Berlin Heidelberg.

[69]  K. Jellinger Vascular-ischemic dementia: an update. , 2002, Journal of neural transmission. Supplementum.

[70]  M. Kraut,et al.  Diffusion tensor MR imaging of the brain and white matter tractography. , 2002, AJR. American journal of roentgenology.

[71]  G. Small,et al.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[72]  F Aichner,et al.  Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. , 2002, Neurology.

[73]  F. Träber,et al.  In-vivo proton MR-spectroscopy of the human brain: Assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration , 2002, Amino Acids.

[74]  H. Hanyu,et al.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. , 2002, AJNR. American journal of neuroradiology.

[75]  Charles DeCarli,et al.  Radial width of the temporal horn: a sensitive measure in Alzheimer disease. , 2002, AJNR. American journal of neuroradiology.

[76]  N. Schuff,et al.  MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease , 2001, Neurology.

[77]  G. Alexander,et al.  Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.

[78]  N. Schuff,et al.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[79]  W. Bradley Normal pressure hydrocephalus and deep white matter ischemia: which is the chicken, and which is the egg? , 2001, AJNR. American journal of neuroradiology.

[80]  M. Ferrari,et al.  Cerebral microbleeds in CADASIL , 2001, Neurology.

[81]  F. Jessen,et al.  Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients , 2001, Neurology.

[82]  A. Colchester,et al.  MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. , 2001, Clinical radiology.

[83]  M. Bobinski,et al.  Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Nick C Fox,et al.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.

[85]  H. Hanyu,et al.  Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer's disease , 2001, Journal of the Neurological Sciences.

[86]  H. Hanyu,et al.  Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy , 2001, Neuroradiology.

[87]  L Solymosi,et al.  Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. , 2001, Archives of neurology.

[88]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[89]  J. Hardy,et al.  Prevalence of Alzheimer’s disease in very elderly people , 2001, Neurology.

[90]  A E George,et al.  What role does functional MR imaging play in the diagnosis or prediction of future-onset Alzheimer's disease? , 2001, AJNR. American journal of neuroradiology.

[91]  R. Floris,et al.  Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. , 2001, AJNR. American journal of neuroradiology.

[92]  J. Hodges Frontotemporal dementia (Pick’s disease): Clinical features and assessment , 2001, Neurology.

[93]  J T O'Brien,et al.  Combined Magnetic Resonance Imaging and Single-Photon Emission Tomography Scanning in the Discrimination of Alzheimer's Disease From Age-Matched Controls , 2001, International Psychogeriatrics.

[94]  G. Frisoni,et al.  Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools , 2001, Journal of neurology, neurosurgery, and psychiatry.

[95]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[96]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[97]  B. Miller,et al.  CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .

[98]  T. Erkinjuntti Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD. , 2001, International journal of clinical practice. Supplement.

[99]  R. V. Van Heertum,et al.  SPECT perfusion imaging in the diagnosis of Alzheimer’s disease , 2001, Neurology.

[100]  C. Jack,et al.  Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. , 2001, Radiology.

[101]  B L Miller,et al.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.

[102]  J D Fenwick,et al.  Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD , 2001, Neurology.

[103]  P Sachdev,et al.  Magnetic resonance spectroscopy in AD , 2001, Neurology.

[104]  K. Ishii,et al.  Occipital Glucose Metabolism in Dementia with Lewy Bodies with and without Parkinsonism: A Study Using Positron Emission Tomography , 2001, Dementia and Geriatric Cognitive Disorders.

[105]  M N Rossor,et al.  Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease , 2001, Annals of neurology.

[106]  C Gössl,et al.  Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. , 2001, Radiology.

[107]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[108]  Murat Emre,et al.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study , 2000, The Lancet.

[109]  M W Weiner,et al.  Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease , 2000, Neurology.

[110]  A. Kertesz,et al.  The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia , 2000, Neurology.

[111]  L. Defebvre,et al.  Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to 99mTc HmPAO SPECT data , 2000, Journal of neurology, neurosurgery, and psychiatry.

[112]  M. Witter,et al.  Functional MR imaging in Alzheimer's disease during memory encoding. , 2000, AJNR. American journal of neuroradiology.

[113]  P Julin,et al.  Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[114]  F. Tison,et al.  Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.

[115]  S. Rose,et al.  Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.

[116]  E. Mori [Dementia with Lewy bodies]. , 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[117]  K. Marder,et al.  The Role of Routine Laboratory Studies and Neuroimaging in the Diagnosis of Dementia: A Clinicopathological Study , 2000, Journal of the American Geriatrics Society.

[118]  W. Bradley,et al.  Normal pressure hydrocephalus: new concepts on etiology and diagnosis. , 2000, AJNR. American journal of neuroradiology.

[119]  F Träber,et al.  Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD , 2000, Neurology.

[120]  H. Gertz,et al.  Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study , 2000, International journal of geriatric psychiatry.

[121]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[122]  Anders Wallin,et al.  Frontotemporal Dementia Can Be Distinguished from Alzheimer’s Disease and Subcortical White Matter Dementia by an Anterior-to-Posterior rCBF-SPET Ratio , 2000, Dementia and Geriatric Cognitive Disorders.

[123]  H. Braak,et al.  Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe , 2000 .

[124]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[125]  E G Tangalos,et al.  Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.

[126]  K. Jellinger Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia , 2000, Journal of neurology, neurosurgery, and psychiatry.

[127]  J. Saver,et al.  Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis. , 2000, Stroke.

[128]  G. Frisoni,et al.  Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer’s disease: a morphometric MRI study , 2000, Biological Psychiatry.

[129]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[130]  C. Jack,et al.  Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.

[131]  James W Ironside,et al.  The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease , 2000, The Lancet.

[132]  Elna-Marie Larsson,et al.  Magnetic Resonance Imaging and Histopathology in Dementia, Clinically of Frontotemporal Type , 2000, Dementia and Geriatric Cognitive Disorders.

[133]  P. Scheltens,et al.  Preliminary Results from an MRI/CT‐Based Database for Vascular Dementia and Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[134]  M. Esiri Which Vascular Lesions Are of Importance in Vascular Dementia? , 2000, Annals of the New York Academy of Sciences.

[135]  I G McKeith,et al.  MRI volumetric study of dementia with Lewy bodies , 2000, Neurology.

[136]  R. Anand,et al.  An efficacy and safety analysis of Exelon® in Alzheimer’s disease patients with concurrent vascular risk factors , 2000, European journal of neurology.

[137]  C. Jack,et al.  Memory and MRI-based hippocampal volumes in aging and AD , 2000, Neurology.

[138]  V. Hachinski,et al.  Prevalence and outcomes of vascular cognitive impairment , 2000, Neurology.

[139]  J. Adair,et al.  Diffusion-weighted MRI in vascular dementia , 2000, Neurology.

[140]  J. Detre,et al.  Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.

[141]  G C Roman,et al.  Research criteria for subcortical vascular dementia in clinical trials. , 2000, Journal of neural transmission. Supplementum.

[142]  The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group. , 2000, Neurology.

[143]  M. Grisoli,et al.  Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias. , 2000, Advances in neurology.

[144]  H. Braak,et al.  Sequence of Abeta-protein deposition in the human medial temporal lobe. , 2000, Journal of neuropathology and experimental neurology.

[145]  V. Hachinski,et al.  Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. , 2000, Neurology.

[146]  J. Vanneste,et al.  Diagnosis and management of normal-pressure hydrocephalus , 2000, Journal of Neurology.

[147]  J. Finsterer,et al.  Hypothyroid Myopathy with Unusually High Serum Creatine Kinase Values , 2000, Hormone Research in Paediatrics.

[148]  NMR microscopy--beginnings and new directions. , 1999 .

[149]  M. Bobinski,et al.  The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.

[150]  A. Lang,et al.  Dementia as the most common presentation of cortical-basal ganglionic degeneration , 1999, Neurology.

[151]  D. Le Bihan,et al.  Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. , 1999, Stroke.

[152]  G A Johnson,et al.  Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[153]  B. Winblad,et al.  Assessing the societal impact of acetylcholinesterase inhibitor therapies. , 1999, Alzheimer Disease and Associated Disorders.

[154]  Charles D. Smith,et al.  Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. , 1999, Neurology.

[155]  R N Kalaria,et al.  Overlap between pathology of Alzheimer disease and vascular dementia. , 1999, Alzheimer disease and associated disorders.

[156]  Zsuzsanna Nagy,et al.  Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease , 1999, The Lancet.

[157]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[158]  J. Brandt,et al.  Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. , 1999, Brain : a journal of neurology.

[159]  D. Radice,et al.  Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy , 1999, Neurology.

[160]  Philip Scheltens,et al.  Visual assessment of medial temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry , 1999, Psychiatry Research: Neuroimaging.

[161]  Linda Teri,et al.  Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.

[162]  S. Shimizu,et al.  Dural arteriovenous malformation manifesting as dementia due to ischemia in bilateral thalami. A case report. , 1999, Surgical neurology.

[163]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[164]  I G McKeith,et al.  Medial temporal lobe atrophy on MRI in dementia with Lewy bodies , 1999, Neurology.

[165]  P Kapeller,et al.  Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. , 1999, AJNR. American journal of neuroradiology.

[166]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[167]  R. Edelman,et al.  Diffusion-Weighted Magnetic Resonance Imaging in Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.

[168]  P. Lantos,et al.  Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies , 1999, British Journal of Psychiatry.

[169]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[170]  P. Scheltens,et al.  Vascular dementia: the role of cerebral infarcts. , 1999, Alzheimer disease and associated disorders.

[171]  Vascular factors and Alzheimer disease. , 1999, Alzheimer disease and associated disorders.

[172]  N. Mai,et al.  Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). , 1999, AJNR. American journal of neuroradiology.

[173]  H. Soininen,et al.  Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. , 1999, AJNR. American journal of neuroradiology.

[174]  F. Pasquier,et al.  Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[175]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[176]  P F Renshaw,et al.  Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. , 1998, AJNR. American journal of neuroradiology.

[177]  A. Smith,et al.  Comparison of Pathological Diagnostic Criteria for Alzheimer Disease , 1998, Alzheimer disease and associated disorders.

[178]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[179]  J. Trojanowski,et al.  Dementia resulting from dural arteriovenous fistulas: the pathologic findings of venous hypertensive encephalopathy. , 1998, AJNR. American journal of neuroradiology.

[180]  Changiz Geula,et al.  Abnormalities of neural circuitry in Alzheimer's disease , 1998, Neurology.

[181]  R. Mohs,et al.  Cerebral infarcts in patients with autopsy-proven Alzheimer's disease , 1998, Neurology.

[182]  B L Holman,et al.  Preclinical prediction of Alzheimer's disease using SPECT , 1998, Neurology.

[183]  K. Krishnan,et al.  Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy , 1998, Psychiatry Research: Neuroimaging.

[184]  H. Hanyu,et al.  Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease , 1998, Journal of the Neurological Sciences.

[185]  G. Fein,et al.  Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. , 1998, Radiology.

[186]  H J Testa,et al.  A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? , 1998, Journal of neurology, neurosurgery, and psychiatry.

[187]  A D Roses,et al.  Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. , 1998, The New England journal of medicine.

[188]  H. Bokura,et al.  Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study , 1998, Journal of Neurology.

[189]  F Barkhof,et al.  Cine phase-contrast MR imaging in normal pressure hydrocephalus patients: relation to surgical outcome. , 1998, Acta neurochirurgica. Supplement.

[190]  H. Braak,et al.  Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria , 1998, Journal of Neural Transmission.

[191]  G. Fein,et al.  Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease , 1997, Neurology.

[192]  D. Leys,et al.  Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. , 1997, Stroke.

[193]  K. Jellinger Clinical-neuropathologic findings in multi-infarct dementia: A report of six autopsied cases , 1997, Neurology.

[194]  Mari Yoshida,et al.  Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy — study in autopsy cases , 1997, Journal of the Neurological Sciences.

[195]  J T O'Brien,et al.  Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment , 1997, Psychological Medicine.

[196]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[197]  S H Ferris,et al.  Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. , 1997, JAMA.

[198]  C. Jack,et al.  Hippocampal transverse relaxation times in patients with Alzheimer disease. , 1997, Radiology.

[199]  J. Morris,et al.  Current concepts in the pathogenesis of Alzheimer's disease. , 1997, The American journal of medicine.

[200]  V. Hachinski,et al.  Cerebrovascular Pathology in Alzheimer's Disease: Cause, Effect or Epiphenomenon? , 1997, Annals of the New York Academy of Sciences.

[201]  H. Fukuyama,et al.  Cerebral glucose metabolism in corticobasal degeneration: Comparison with progressive supranuclear palsy and normal controls , 1997, Movement disorders : official journal of the Movement Disorder Society.

[202]  P. Mcgeer,et al.  Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam , 1997, Neurology.

[203]  T. Yanagihara,et al.  Imaging in primary progressive aphasia , 1997, Neuroradiology.

[204]  G C Roman,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[205]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[206]  M. Bobinski,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[207]  Janice E Graham,et al.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population , 1997, The Lancet.

[208]  T Ernst,et al.  Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. , 1997, Radiology.

[209]  F Barkhof,et al.  The Diagnostic Value of Magnetic Resonance Imaging and Technetium 99m‐HMPAO Single‐Photon-Emission Computed Tomography for the Diagnosis of Alzheimer Disease in a Community‐Dwelling Elderly Population , 1997, Alzheimer disease and associated disorders.

[210]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[211]  H. Fukuyama,et al.  Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy , 1997, Annals of neurology.

[212]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[213]  Florence Pasquier,et al.  Why are stroke patients prone to develop dementia? , 1997, Journal of Neurology.

[214]  A. Smith,et al.  The Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[215]  J. P. Brandel,et al.  Accuracy of the Clinical Diagnosis of Corticobasal Degeneration , 1997, Neurology.

[216]  H. Braak,et al.  Staging of Alzheimer-related cortical destruction. , 1997, International psychogeriatrics.

[217]  G A Johnson,et al.  Magnetic resonance microscopy of embryos. , 1996, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[218]  J R Hodges,et al.  Nonfluent progressive aphasia and semantic dementia: A comparative neuropsychological study , 1996, Journal of the International Neuropsychological Society.

[219]  T. Jones,et al.  Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease , 1996, The Lancet.

[220]  L. Fried,et al.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.

[221]  M. Pericak-Vance,et al.  Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease , 1996, The Lancet.

[222]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[223]  Sandra E. Black,et al.  Focal Cortical Atrophy Syndromes , 1996, Brain and Cognition.

[224]  H. Soininen,et al.  MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment , 1996, Neurobiology of Aging.

[225]  S. Finklestein,et al.  Petechial hemorrhages accompanying lobar hemorrhage , 1996, Neurology.

[226]  I. Zerr,et al.  MR imaging of Creutzfeldt-Jakob disease. , 1996, Radiology.

[227]  H. Soininen,et al.  Severity of hippocampal atrophy correlates with the prolongation of MRI T sub 2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease , 1996, Neurology.

[228]  H. Braak,et al.  Age, neurofibrillary changes, Aβ-amyloid and the onset of Alzheimer's disease , 1996, Neuroscience Letters.

[229]  J. Pettegrew,et al.  Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain , 1996, Neurobiology of Aging.

[230]  G. Frisoni,et al.  Linear measures of atrophy in mild Alzheimer disease. , 1996, AJNR. American journal of neuroradiology.

[231]  V Hachinski,et al.  Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. , 1996, Archives of neurology.

[232]  H. Soininen,et al.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia , 1996, Neurology.

[233]  F. Fazekas,et al.  MR of cerebral abnormalities concomitant with primary intracerebral hematomas. , 1996, AJNR. American journal of neuroradiology.

[234]  W G Bradley,et al.  Normal-pressure hydrocephalus: evaluation with cerebrospinal fluid flow measurements at MR imaging. , 1996, Radiology.

[235]  D. Dickson,et al.  Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration , 1996, Journal of neuropathology and experimental neurology.

[236]  H. Braak,et al.  Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease. , 1996, Neuroscience letters.

[237]  Chickering Jg,et al.  Innervation of propatagial musculature in a flying squirrel, Glaucomys volans (Rodentia, Sciuridae). , 1996 .

[238]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.

[239]  M. Hutchinson,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR findings. , 1995, AJNR. American journal of neuroradiology.

[240]  H. Tohgi,et al.  MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report. , 1995, AJNR. American journal of neuroradiology.

[241]  E F Halpern,et al.  Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. , 1995, AJNR. American journal of neuroradiology.

[242]  O L Lopez,et al.  Computed tomography--but not magnetic resonance imaging--identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. , 1995, Archives of neurology.

[243]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[244]  B D Ross,et al.  Probable Alzheimer disease: diagnosis with proton MR spectroscopy. , 1995, Radiology.

[245]  M. Gearing,et al.  The CERAD experience, part VIII , 1995, Neurology.

[246]  C. Loeb Dementia due to lacunar infarctions: a misnomer or a clinical entity? , 1995, European neurology.

[247]  R. Steen,et al.  Age‐related changes in proton T1 values of normal human brain , 1995, Journal of magnetic resonance imaging : JMRI.

[248]  H. Groenewegen,et al.  Anthony H.M. Lohman: reflections on a distinguished career in anatomy. , 1995, Brain, behavior and evolution.

[249]  O. Henriksen,et al.  Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. , 1995, Magnetic resonance imaging.

[250]  J. O'Brien,et al.  Volumetric and visual assessment of the mesial temporal structures in Alzheimer's disease. , 1994, Australian and New Zealand journal of medicine.

[251]  T. Ernst,et al.  Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.

[252]  A. Hofman,et al.  Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study , 1994, Neurology.

[253]  Bertil Olsson,et al.  Cerebral Lesions on Magnetic Resonance Imaging, Heart Disease, and Vascular Risk Factors in Subjects Without Stroke: A Population‐Based Study , 1994, Stroke.

[254]  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[255]  D. Benson,et al.  Posterior Cortical Atrophy: Neuropathologic Correlations , 1994 .

[256]  R I Grossman,et al.  Magnetization transfer: theory and clinical applications in neuroradiology. , 1994, Radiographics : a review publication of the Radiological Society of North America, Inc.

[257]  D Comar,et al.  Differential diagnosis of Alzheimer's disease with PET. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[258]  M Kouwenhoven,et al.  Phase-Contrast Cine Mr Imaging of Normal Aqueductal CSF Flow , 1994, Acta radiologica.

[259]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[260]  H. Eiberg,et al.  Linkage studies of cholestasis familiaris groenlandica/Byler-like disease with polymorphic protein and blood group markers. , 1993, Human heredity.

[261]  B D Ross,et al.  Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.

[262]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[263]  A. Smith,et al.  Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography , 1992, The Lancet.

[264]  J. Growdon,et al.  Treatment for Alzheimer's disease? , 1992, The New England journal of medicine.

[265]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[266]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. , 1992, Brain : a journal of neurology.

[267]  B L Miller,et al.  Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. , 1992, Archives of neurology.

[268]  Donald S. Williams,et al.  Magnetic resonance imaging of perfusion using spin inversion of arterial water , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[269]  G D Pearlson,et al.  Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. , 1992, Archives of general psychiatry.

[270]  P. Anslow,et al.  Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[271]  J. Besson,et al.  Post-mortem Proton Magnetic Resonance Spectrometric Measures of Brain Regions in Patients with a Pathological Diagnosis of Alzheimer's Disease and Multi-infarct Dementia , 1992, British Journal of Psychiatry.

[272]  Larry L. Butcher,et al.  Prolongation of magnetic resonance T 2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease , 1992, Neuroscience Letters.

[273]  C. Jack,et al.  MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.

[274]  P. Ince,et al.  Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients , 1991, Journal of the Neurological Sciences.

[275]  F. Fazekas,et al.  The morphologic correlate of incidental punctate white matter hyperintensities on MR images. , 1991, AJNR. American journal of neuroradiology.

[276]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[277]  W G Bradley,et al.  Marked cerebrospinal fluid void: indicator of successful shunt in patients with suspected normal-pressure hydrocephalus. , 1991, Radiology.

[278]  D. Le Bihan Molecular diffusion nuclear magnetic resonance imaging. , 1991, Magnetic resonance quarterly.

[279]  D. Munoz The pathological basis of multi-infarct dementia. , 1991, Alzheimer disease and associated disorders.

[280]  W. Bradley,et al.  Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normal-pressure hydrocephalus. , 1991, AJNR. American journal of neuroradiology.

[281]  D. Tank,et al.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[282]  S. Ogawa Brain magnetic resonance imaging with contrast-dependent oxygenation , 1990 .

[283]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[284]  G. Paulson,et al.  Magnetic resonance imaging in dementia of Parkinson's disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[285]  Gwenn S. Smith,et al.  EARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS , 1989, The Lancet.

[286]  H. Braak,et al.  Alzheimer's disease: Mismatch between amyloid plaques and neuritic plaques , 1989, Neuroscience Letters.

[287]  P Soliveri,et al.  MR Imaging in Progressive Supranuclear Palsy and Shy‐Drager Syndrome , 1989, Journal of computer assisted tomography.

[288]  N. Quinn,et al.  Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[289]  M. LeMay,et al.  Temporal lobe atrophy in patients with Alzheimer disease: a CT study. , 1989, AJNR. American journal of neuroradiology.

[290]  R. Balaban,et al.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.

[291]  D. Knopman,et al.  The spectrum of imaging and neuropsychological findings in Pick's disease , 1989, Neurology.

[292]  S. Rosini,et al.  Effects of diacerein on the quantity and phagocytic activity of thioglycollate-elicited mouse peritoneal macrophages. , 1989, Pharmacology.

[293]  J. Harrison,et al.  Posterior cortical atrophy. , 1989, Clinical and experimental neurology.

[294]  W. Jagust,et al.  Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease , 1988, Magnetic resonance in medicine.

[295]  J. Pettegrew,et al.  Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease. , 1988, Archives of neurology.

[296]  J. Trojanowski,et al.  Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. , 1988, AJR. American journal of roentgenology.

[297]  J. Pettegrew,et al.  31P Nuclear Magnetic Resonance Study of the Brain in Alzheimer's Disease , 1988, Journal of neuropathology and experimental neurology.

[298]  B. Drayer,et al.  Imaging of the aging brain. Part II. Pathologic conditions. , 1988, Radiology.

[299]  M Haupt,et al.  [Clinical diagnosis of Alzheimer's disease]. , 1988, Deutsche medizinische Wochenschrift.

[300]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[301]  M. Tierney,et al.  The Differential Diagnosis of Alzheimer's Disease: Conceptual and Methodological Issues , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[302]  R F Spetzler,et al.  Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. , 1986, Stroke.

[303]  W. Bradley,et al.  Flowing cerebrospinal fluid in normal and hydrocephalic states: appearance on MR images. , 1986, Radiology.

[304]  J. Vanneste,et al.  Non-tumoural aqueduct stenosis and normal pressure hydrocephalus in the elderly. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[305]  C. Derouesné,et al.  [The concept of cerebral lacunae from 1838 to the present]. , 1985, Revue neurologique.

[306]  C. Derouesné,et al.  Cerebral lacunae. A proposed new classification. , 1984, Clinical neuropathology.

[307]  C. Fisher Lacunar strokes and infarcts , 1982, Neurology.

[308]  J. Coyle,et al.  Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis , 1981, Annals of neurology.

[309]  D. Davies,et al.  MYOCARDIAL DISORDERS IN THE ELDERLY. , 1963, Lancet.

[310]  R. Webster Magnetic Resonance Spectroscopy , 1962, Nature.

[311]  J. W. Papez A PROPOSED MECHANISM OF EMOTION , 1937 .

[312]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .